Patent · US Active

Persistent luminescence nanoparticles excitable in situ for in vivo optical imaging, in vivo multimodal optical—MRI imaging, and theranostics

US9877653B2 · kind B2 · utility

1Cited by
2References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 30, 2013
Grant dateJan 30, 2018
Priority date
Expiry dateApr 30, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC01P2006/90
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Multimodal optical and magnetic resonance imaging methods based on the use of persistent luminescence nanoparticles. Use of mesoporous persistent luminescence <<core-shell>> complexes for theranostic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.